1st Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$330,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2015 $330,000 Replaced
1st Quarter - Amendment Sep 21, 2015 $210,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to SGR Issues related to Medicaid

LobbyistCovered position, as disclosed
JESSICA JOHNSTON New —
TODD SPANGLER New —

Contacted: Food & Drug Administration (FDA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; SENATE; Natl Economic Council (NEC); Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

NIH Funding BARDA Funding

LobbyistCovered position, as disclosed
JESSICA JOHNSTON New —
JENNIFER M LURAY —
DANNY LY —
ELIZABETH WOODY —

Contacted: SENATE; Food & Drug Administration (FDA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Centers For Disease Control & Prevention (CDC)

Taxation/Internal Revenue Code TAX

Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax

LobbyistCovered position, as disclosed
JESSICA JOHNSTON New —
DANNY LY —
TODD SPANGLER New —
ELIZABETH WOODY —

Contacted: Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Treasury, Dept of; Food & Drug Administration (FDA); SENATE

Bills named: S. 149 (114th), H.R. 160 (114th)

Trade (domestic/foreign) TRD

Issues related to Trade Promotion Authority (TPA) Issues related to Trans-Pacific Partnership (TPP)

LobbyistCovered position, as disclosed
TODD SPANGLER New —

Contacted: Natl Economic Council (NEC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Treasury, Dept of; SENATE

Health Issues HCR

Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation

LobbyistCovered position, as disclosed
JESSICA JOHNSTON New —
JENNIFER M LURAY —
DANNY LY —
TODD SPANGLER New —
ELIZABETH WOODY —

Contacted: Treasury, Dept of; Centers For Disease Control & Prevention (CDC); SENATE; Natl Economic Council (NEC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.